InflaRx ends its Phase 3 trial of vilobelimab in pyoderma gangrenosum and shifts focus to INF904 amid efforts to extend its ...

InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement ...

After a poor showing of its COVID med vilobelimab in a rare skin disorder trial, German drugmaker InflaRx is going back to ...

Colugo Camp (Opening Q3 2025): A permanent overnight glamping destination featuring safari-style tents, meals, and guided ...

Patient groups with reduced odds for extracorporeal membrane oxygenation had shorter travel distances to a hospital with this ...

Warning: This story contains content that might upset some readers. An extraordinary medical intervention is helping to keep some of the nation's sickest children alive. Known as ECMO, it's a ...

This method shows the importance of starting rehab whilst patients were still critically ill. The National University Heart ...

The U.S. Food and Drug Administration has approved GSK's Nucala (mepolizumab) as an add-on maintenance treatment for adult ...

Older adults requiring long-term care frequently experience multiple disabilities, with considerable variation in the ...

Eric Topol’s sprightly seniors had very few genetic similarities, which meant their longevity had to come down to lifestyle ...

A scientific statement has been published by the AHA regarding palliative care and advanced cardiovascular disease in adults.